z-logo
open-access-imgOpen Access
Targeted Delivery of Glucan Particle Encapsulated Gallium Nanoparticles Inhibits HIV Growth in Human Macrophages
Author(s) -
Ernesto R. Soto,
Olivia O’Connell,
Fusun Dikengil,
Paul J. Peters,
Paul R. Clapham,
Gary R. Ostroff
Publication year - 2016
Publication title -
journal of drug delivery
Language(s) - English
Resource type - Journals
eISSN - 2090-3014
pISSN - 2090-3022
DOI - 10.1155/2016/8520629
Subject(s) - human immunodeficiency virus (hiv) , nanoparticle , glucan , nanotechnology , particle (ecology) , gallium , chemistry , microbiology and biotechnology , virology , materials science , medicine , biology , biochemistry , ecology , organic chemistry
Glucan particles (GPs) are hollow, porous 3–5  μ m microspheres derived from the cell walls of Baker's yeast ( Saccharomyces cerevisiae). The 1,3- β -glucan outer shell provides for receptor-mediated uptake by phagocytic cells expressing β -glucan receptors. GPs have been used for macrophage-targeted delivery of a wide range of payloads (DNA, siRNA, protein, small molecules, and nanoparticles) encapsulated inside the hollow GPs or bound to the surface of chemically derivatized GPs. Gallium nanoparticles have been proposed as an inhibitory agent against HIV infection. Here, macrophage targeting of gallium using GPs provides for more efficient delivery of gallium and inhibition of HIV infection in macrophages compared to free gallium nanoparticles.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom